ARCHIVES

Vaccine and LDCT Pretreatment Can Help PDACs Become Vulnerable to Immunotherapy

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Sharfstein To Leave FDA

January 7, 2011

Men With Low PSA Scores May Not Need Annual Tests, Data From PLCO Trial Suggests

May 31, 2002

In Brief: Pittsburgh Joins List Of Comprehensive Center Prospect; FDA Schedules Meeting On Cancer Drugs

July 11, 1975

NCI-Approved Clinical Trials

September 29, 2006

More DCT Concepts Approved By Advisors

July 10, 1992

In Brief: Lawyers Halt Reference Chemical Distribution To Grantees, Threaten To Stop Viruses, Animals

September 2, 1977